- Home
- OLMA vs KOP Comparison
OLMA vs KOP Comparison
Compare OLMA & KOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLMA
- KOP
- Stock Information
- Founded
- OLMA 2006
- KOP 1988
- Country
- OLMA United States
- KOP United States
- Employees
- OLMA N/A
- KOP N/A
- Industry
- OLMA Biotechnology: Pharmaceutical Preparations
- KOP Forest Products
- Sector
- OLMA Health Care
- KOP Basic Materials
- Exchange
- OLMA Nasdaq
- KOP Nasdaq
- Market Cap
- OLMA 560.7M
- KOP 550.1M
- IPO Year
- OLMA 2020
- KOP 2006
- Fundamental
- Price
- OLMA $10.48
- KOP $26.49
- Analyst Decision
- OLMA Strong Buy
- KOP Strong Buy
- Analyst Count
- OLMA 5
- KOP 2
- Target Price
- OLMA $24.00
- KOP $52.50
- AVG Volume (30 Days)
- OLMA 1.2M
- KOP 179.9K
- Earning Date
- OLMA 11-11-2025
- KOP 11-07-2025
- Dividend Yield
- OLMA N/A
- KOP 1.21%
- EPS Growth
- OLMA N/A
- KOP N/A
- EPS
- OLMA N/A
- KOP 0.73
- Revenue
- OLMA N/A
- KOP $1,992,600,000.00
- Revenue This Year
- OLMA N/A
- KOP N/A
- Revenue Next Year
- OLMA N/A
- KOP $2.35
- P/E Ratio
- OLMA N/A
- KOP $36.24
- Revenue Growth
- OLMA N/A
- KOP N/A
- 52 Week Low
- OLMA $2.86
- KOP $22.99
- 52 Week High
- OLMA $13.51
- KOP $39.83
- Technical
- Relative Strength Index (RSI)
- OLMA 70.04
- KOP 30.50
- Support Level
- OLMA $8.01
- KOP $26.22
- Resistance Level
- OLMA $11.54
- KOP $28.07
- Average True Range (ATR)
- OLMA 0.79
- KOP 0.70
- MACD
- OLMA 0.14
- KOP -0.15
- Stochastic Oscillator
- OLMA 72.61
- KOP 5.41
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
About KOP Koppers Holdings Inc.
Koppers Holdings Inc through its subsidiaries, manufactures and sells wood products, wood treatment chemicals, and carbon compounds used in markets such as railroad, aluminum and steel, agriculture, utilities, and residential lumber. The company is organized into three business segments: railroad and utility products and services, performance chemicals, and carbon materials and chemicals. Its product portfolio includes treated and untreated wood products like crossties used in railroads, wood preservation chemicals, and carbon compounds such as creosote used in the treatment of wood crossties, among others. The majority of its revenue comes from the company's railroad and utility products and services segment, and more than half of the company's revenue is earned in the United States.